Interleukin‐15‐activated natural killer cells kill autologous osteoclasts via LFA‐1, DNAM‐1 and TRAIL, and inhibit osteoclast‐mediated bone erosion in vitro
- 19 May 2015
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 145 (3) , 367-379
Abstract
Osteoclasts reside on bone and are the main bone resorbing cells playing an important role in bone homeostasis, while natural killer (NK) cells are bone‐marrow‐derived cells known to play a crucial role in immune defence against viral infections. Although mature NK cells traffic through bone marrow as well as to inflammatory sites associated with enhanced bone erosion, including the joints of patients with rheumatoid arthritis, little is known about the impact NK cells may have on mature osteoclasts and bone erosion. We studied the interaction between human NK cells and autologous monocyte‐derived osteoclasts from healthy donors in vitro. We show that osteoclasts express numerous ligands for receptors present on activated NK cells. Co‐culture experiments revealed that interleukin‐15‐activated, but not resting, NK cells trigger osteoclast apoptosis in a dose‐dependent manner, resulting in drastically decreased bone erosion. Suppression of bone erosion requires contact between NK cells and osteoclasts, but soluble factors also play a minor role. Antibodies masking leucocyte function‐associated antigen‐1, DNAX accessory molecule‐1 or tumour necrosis factor‐related apoptosis‐inducing ligand enhance osteoclast survival when co‐cultured with activated NK cells and restore the capacity of osteoclasts to erode bone. These results suggest that interleukin‐15‐activated NK cells may directly affect bone erosion under physiological and pathological conditions.Keywords
Funding Information
- Danish Agency for Science, Technology and Innovation (Industrial PhD study)
This publication has 48 references indexed in Scilit:
- Activated monocytes augment TRAIL‐mediated cytotoxicity by human NK cells through release of IFN‐γEuropean Journal of Immunology, 2012
- Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2APLOS ONE, 2012
- Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early ArthritisPLOS ONE, 2011
- Natural killer cells trigger osteoclastogenesis and bone destruction in arthritisProceedings of the National Academy of Sciences, 2009
- Human natural killer cellsBlood, 2008
- The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosisApoptosis, 2007
- Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretionImmunology, 2007
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast developmentBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Interleukin-4 as a potent inhibitor of bone resorptionBiochemical and Biophysical Research Communications, 1990